|
|
|
Insider
Information: |
Mclaughlin Kevin F |
Relationship: |
Director |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
11,900 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$547,043 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
11,900 |
|
|
Total
Value |
$547,043 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,900 |
2020-04-29 |
0 |
Premium* |
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-01-03 |
4 |
OE |
$3.88 |
$38,800 |
D/D |
10,000 |
72,600 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-01-04 |
4 |
AS |
$26.87 |
$46,667 |
D/D |
(1,700) |
70,900 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,900 |
77,800 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-07-05 |
4 |
OE |
$5.28 |
$150,132 |
D/D |
21,900 |
99,700 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-07-05 |
4 |
AS |
$32.00 |
$1,100,800 |
D/D |
(34,400) |
65,300 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2017-09-12 |
4 |
AS |
$38.32 |
$614,546 |
D/D |
(16,000) |
49,300 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-01-02 |
4 |
AS |
$42.42 |
$169,680 |
D/D |
(4,000) |
45,300 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-01-03 |
4 |
OE |
$3.88 |
$57,254 |
D/D |
12,501 |
57,801 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-01-04 |
4 |
AS |
$43.00 |
$645,168 |
D/D |
(15,000) |
42,801 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,138 |
47,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-04-03 |
4 |
AS |
$38.31 |
$153,792 |
D/D |
(4,000) |
43,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-06-29 |
4 |
AS |
$47.00 |
$1,200,000 |
D/D |
(25,000) |
43,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-06-29 |
4 |
OE |
$24.11 |
$602,750 |
D/D |
25,000 |
68,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-08-30 |
4 |
OE |
$27.97 |
$349,625 |
D/D |
12,500 |
56,439 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2018-08-30 |
4 |
AS |
$54.00 |
$675,000 |
D/D |
(12,500) |
43,939 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-01-02 |
4 |
AS |
$42.37 |
$244,494 |
D/D |
(5,712) |
38,227 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
42,927 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-04-02 |
4 |
AS |
$48.02 |
$31,117 |
D/D |
(648) |
42,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-04-09 |
4 |
AS |
$44.61 |
$535,405 |
D/D |
(12,000) |
30,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-09-10 |
4 |
AS |
$45.29 |
$362,400 |
D/D |
(8,000) |
22,279 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2019-12-13 |
4 |
AS |
$50.28 |
$595,969 |
D/D |
(11,853) |
10,426 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-01-02 |
4 |
AS |
$52.49 |
$292,923 |
D/D |
(5,579) |
4,847 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,369 |
11,216 |
0 |
- |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-04-08 |
4 |
AS |
$82.83 |
$3,144,614 |
D/D |
(36,774) |
11,216 |
0 |
% |
|
XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
|
2020-04-08 |
4 |
OE |
$24.11 |
$1,204,129 |
D/D |
36,774 |
47,990 |
0 |
- |
|
101 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|